Showing 1 - 2 results of 2 for search 'Edelbaher Natalija', query time: 0.02s Refine Results
  1. 1
    Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutations

    Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutat... by Zwitter Matjaz, Stanic Karmen, Rajer Mirjana, Kern Izidor, Vrankar Martina, Edelbaher Natalija, Kovac Viljem

    Published 2014-12-01
    Get full text
    Article
  2. 2
    Real-world outcomes, treatment patterns and T790M testing rates in non-small cell lung cancer patients treated with first-line first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors from the Slovenian cohort of the REFLECT study

    Real-world outcomes, treatment patterns and T790M testing rates in non-small cell lung cancer patients treated with first-line first- or second-generation epidermal growth factor r... by Turnsek Nina, Devjak Rok, Edelbaher Natalija, Osrajnik Ilonka, Unk Mojca, Vidovic Dusanka, Jeric Tina, Janzic Urska

    Published 2022-08-01
    Get full text
    Article

Search Tools: